Spineway

Spineway EV/EBITDA

The EV/EBITDA (Enterprise Value to EBITDA) of Spineway (ALSPW.PA) as of Nov 3, 2026 is -2.28. In the previous year, EV/EBITDA (Enterprise Value to EBITDA) was -0.85 — a change of 166.93% (lower).

EV/EBITDA

-2.28

YoY

166.93%

Last updated:

EV/EBITDA (Enterprise Value to EBITDA) of Spineway is 2025 -2.28 . EV/EBITDA (Enterprise Value to EBITDA) of Spineway was 2024 -0.85 . It decreases by 166.93% lower compared to the previous year.

The Spineway EV/EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBITDA
Date
EV/EBITDA
Jan 1, 2018
-3.82 EUR
Jan 1, 2019
-5.73 EUR
Jan 1, 2020
-5.06 EUR
Jan 1, 2021
5.25 EUR
Jan 1, 2022
-0.45 EUR
Jan 1, 2023
-1.65 EUR
Jan 1, 2024
-0.85 EUR
Jan 1, 2025
-2.28 EUR
The Spineway EV/EBITDA history
YEAREV/EBITDAYoY
-2.28+166.93%
-0.85-48.33%
-1.65+268.23%
-0.45-108.53%
5.25-203.83%
-5.06-11.77%
-5.73+49.95%
-3.82-97.67%
-164.02+2,975.24%
-5.33-42.65%
-9.30+23.71%
-7.52—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Spineway Stock analysis

What does Spineway do? Spineway SA, listed on the Paris Stock Exchange under the ticker ALSPW.PA, is a healthcare company based in Ecully, France. The company, which went public on February 8, 2013, focuses on the design, production, and sale of spinal column implants and surgical instruments. Spineway employs 35 full-time staff and operates within the healthcare sector, specifically in the health care industry. The company's product portfolio includes spinal systems, cervical and lumbar cages, cervical plates, and bone substitutes. Spineway SA is headquartered in the Auvergne-Rhône-Alpes region, reflecting its local presence in a key French economic area. The company's website is www.spineway.com, providing access to further information about its operations and offerings. Spineway SA has not reported any acquisitions, specific founding year, or additional details beyond its current operational scope and employee count. The company's activities are centered on medical devices for spinal care, targeting healthcare providers and surgical professionals. Spineway is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spineway stock

EV/EBITDA (Enterprise Value to EBITDA) of Spineway is -2.28 in 2025.

EV/EBITDA (Enterprise Value to EBITDA) of Spineway changed from -0.85 to -2.28, representing a 166.93% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBITDA (Enterprise Value to EBITDA) Spineway since 2006 – with annual values, charts, and detailed analysis.

The EV/EBITDA ratio is a widely used valuation metric that compares a company's enterprise value to its EBITDA. It normalizes for differences in capital structure, taxation, and depreciation policies.

To evaluate EV/EBITDA (Enterprise Value to EBITDA)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBITDA (Enterprise Value to EBITDA).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBITDA (Enterprise Value to EBITDA)'s Spineway with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Spineway

All Key Metrics — Spineway